Literature DB >> 21952099

Abenquines A-D: aminoquinone derivatives produced by Streptomyces sp. strain DB634.

Dirk Schulz1, Pascal Beese, Birgit Ohlendorf, Arlette Erhard, Heidi Zinecker, Cristina Dorador, Johannes F Imhoff.   

Abstract

New bioactive secondary metabolites, called abenquines, were found in the fermentation broth of Streptomyces sp. strain DB634, which was isolated from the soils of the Chilean highland of the Atacama Desert. They are composed of an amino acid linked to an N-acetyl-aminobenzoquinone. Isolation of the abenquines (1-4), their structure elucidation by NMR analysis and MS, as well as the kinetics of their production are presented. The abenquines show inhibitory activity against bacteria, dermatophytic fungi and phosphodiesterase type 4b. The amino acid attached to the quinone is relevant to the enzyme inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21952099     DOI: 10.1038/ja.2011.87

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  16 in total

1.  Isolation and anti-HIV-1 integrase activity of lentzeosides A-F from extremotolerant lentzea sp. H45, a strain isolated from a high-altitude Atacama Desert soil.

Authors:  Dominik Wichner; Hamidah Idris; Wael E Houssen; Andrew R McEwan; Alan T Bull; Juan A Asenjo; Michael Goodfellow; Marcel Jaspars; Rainer Ebel; Mostafa E Rateb
Journal:  J Antibiot (Tokyo)       Date:  2016-06-29       Impact factor: 2.649

2.  Acetylcholinesterase inhibitors from a marine fungus Talaromyces sp. strain LF458.

Authors:  Bin Wu; Birgit Ohlendorf; Vanessa Oesker; Jutta Wiese; Susann Malien; Rolf Schmaljohann; Johannes F Imhoff
Journal:  Mar Biotechnol (NY)       Date:  2014-08-10       Impact factor: 3.619

3.  1,4-Benzoquinone antimicrobial agents against Staphylococcus aureus and Mycobacterium tuberculosis derived from scorpion venom.

Authors:  Edson Norberto Carcamo-Noriega; Shyam Sathyamoorthi; Shibdas Banerjee; Elumalai Gnanamani; Monserrat Mendoza-Trujillo; Dulce Mata-Espinosa; Rogelio Hernández-Pando; José Ignacio Veytia-Bucheli; Lourival D Possani; Richard N Zare
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-10       Impact factor: 11.205

4.  Nature's lab for derivatization: new and revised structures of a variety of streptophenazines produced by a sponge-derived Streptomyces strain.

Authors:  Anna Lena Kunz; Antje Labes; Jutta Wiese; Torsten Bruhn; Gerhard Bringmann; Johannes F Imhoff
Journal:  Mar Drugs       Date:  2014-03-25       Impact factor: 5.118

5.  Design and synthesis of novel isoxazole tethered quinone-amino Acid hybrids.

Authors:  P Ravi Kumar; Manoranjan Behera; M Sambaiah; Venu Kandula; Nagaraju Payili; A Jaya Shree; Satyanarayana Yennam
Journal:  J Amino Acids       Date:  2014-11-19

Review 6.  Biotechnological applications derived from microorganisms of the Atacama Desert.

Authors:  Armando Azua-Bustos; Carlos González-Silva
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

Review 7.  Actinobacteria from Arid and Desert Habitats: Diversity and Biological Activity.

Authors:  Fatemeh Mohammadipanah; Joachim Wink
Journal:  Front Microbiol       Date:  2016-01-28       Impact factor: 5.640

8.  Isolation, structure elucidation and total synthesis of lajollamide A from the marine fungus Asteromyces cruciatus.

Authors:  Tobias A M Gulder; Hanna Hong; Jhonny Correa; Ekaterina Egereva; Jutta Wiese; Johannes F Imhoff; Harald Gross
Journal:  Mar Drugs       Date:  2012-12       Impact factor: 5.118

9.  Helicusin E, isochromophilone X and isochromophilone XI: new chloroazaphilones produced by the fungus Bartalinia robillardoides strain LF550.

Authors:  Nils Jansen; Birgit Ohlendorf; Arlette Erhard; Torsten Bruhn; Gerhard Bringmann; Johannes F Imhoff
Journal:  Mar Drugs       Date:  2013-03-12       Impact factor: 5.118

10.  Spirocyclic drimanes from the marine fungus Stachybotrys sp. strain MF347.

Authors:  Bin Wu; Vanessa Oesker; Jutta Wiese; Susann Malien; Rolf Schmaljohann; Johannes F Imhoff
Journal:  Mar Drugs       Date:  2014-04-01       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.